Micro Emerging Active

UBS ने जेस्पर थेरप्यूटिक्स पर कवरेज शुरू किया।

New narrative with limited coverage — still forming.

स्कोर
0.4
गति
▲ 0.0
लेख
4
स्रोत
1

Sentiment Timeline

Event Timeline

अप्र 07, 2026
Evercore ISI Lowers its Price Target on Jasper Therapeutics (JSPR) to $7 Bearish
अप्र 06, 2026
UBS Upgrades JFrog (FROG) to Buy with $60 Price Target on Demand … Bullish
मा 30, 2026
Edgewise Therapeutics, Inc. (EWTX) PT Increased to $45 at JPMorgan Amid Optimism … Bullish
मा 29, 2026
Why UBS Started Jasper Therapeutics (JSPR) at Neutral Despite Progress in Briquilimab Neutral

समयरेखा

पहली बार देखामा 29, 2026
अंतिम अपडेटमा 29, 2026